Does BridgeBio Pharma Inc. (NASDAQ:BBIO) have deteriorating prospects?

BridgeBio Pharma Inc. (NASDAQ:BBIO) shares traded 1.50% higher at $32.52 on Wall Street last session. In accordance with the data, 11 analysts cover BridgeBio Pharma Inc. (NASDAQ:BBIO). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $50.00 and a low of $30.00, […]